Adaptimmune Therapeutics News

Adaptimmune Therapeutics Plc (NASDAQ:ADAP) Not Doing Enough For Some Investors As Its Shares Slump 30%

The Adaptimmune Therapeutics plc (NASDAQ:ADAP) share price has softened a substantial 30% over the previous 30 days, handing back much of the gains the stock has made lately.

Simply Wall StApr 26 07:34 ET

European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading

European equities traded in the US as American depositary receipts jumped Tuesday morning, advancing 1.31% to 1,362.51 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led

MT NewswiresApr 23 11:05 ET

Garry Menzel Joins GHO Capital as Operating Partner

Garry Menzel joins GHO Capital as Operating Partner Former CEO of TCR2 Therapeutics with significant investment and operating experience to support deal origination and provide best in class services to pioneering

GlobeNewswireApr 23 07:45 ET

Leerink Partners Sticks to Its Hold Rating for Adaptimmune Therapeutics (ADAP)

TipRanksApr 22 01:16 ET

12 Health Care Stocks Moving In Friday's After-Market Session

GainersMobile-health Network (NASDAQ:MNDR) shares rose 15.0% to $31.35 during Friday's after-market session. The company's market cap stands at $1.0 billion. Galera Therapeutics (NASDAQ:GRTX) stock in

BenzingaApr 19 16:31 ET

European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down

European equities traded in the US as American depositary receipts were trending higher Friday morning, rising 0.46% to 1,330.20 on the S&P Europe Select ADR Index. Despite the gain, the index remains

MT NewswiresApr 19 11:10 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV) and Adaptimmune Therapeutics (ADAP)

TipRanksApr 19 04:11 ET

European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading

European equities traded in the US as American depositary receipts were treading water in Thursday morning session, nudging 0.006% higher to 1,330.06 on the S&P Europe Select ADR Index. From continent

MT NewswiresApr 18 11:08 ET

Maintaining Buy Rating on Adaptimmune Therapeutics Post-Genentech Collaboration Termination

TipRanksApr 16 02:56 ET

Analysts Offer Insights on Healthcare Companies: Adaptimmune Therapeutics (ADAP) and Immunic (IMUX)

TipRanksApr 16 02:50 ET

Hedge Funds Owners May Take Dramatic Actions as Adaptimmune Therapeutics Plc's (NASDAQ:ADAP) Recent 15% Drop Adds to One-year Losses

Key Insights Significantly high institutional ownership implies Adaptimmune Therapeutics' stock price is sensitive to their trading actions The top 4 shareholders own 56% of the company Recent sa

Simply Wall StApr 15 13:10 ET

Express News | Adaptimmune Therapeutics Shares Are Trading Lower After the Company Said It Received Notice of Termination of the Strategic Collaboration and License Agreement With Genentech and F. Hoffman-La Roche Ltd

Moomoo 24/7Apr 12 11:45 ET

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading

European equities traded in the US as American depositary receipts were lower Friday morning, falling 0.66% to 1,356.48 on the S&P Europe Select ADR Index. The index is poised to close the week down n

MT NewswiresApr 12 11:09 ET

Express News | Adaptimmune Therapeutics Shares Down 3.5% After Roche's Genentech Terminates Deal With Co to Develop Cancer Therapies

Moomoo 24/7Apr 12 09:54 ET

Adaptimmune Slips as Roche Strategic Collaboration Ends

Seeking AlphaApr 12 08:53 ET

Express News | Adaptimmune Therapeutics Says On April 10, Unit Of Co, Received Notice Of Termination Of Strategic Collaboration And License Agreement With Genentech; Termination Will Become Effective 180 Days After Date Of Receipt; As Result Of Termination, Co Not Entit

Moomoo 24/7Apr 12 08:13 ET

Express News | Adaptimmune Therapeutics PLC: Will Also Cease to Have Any Development Obligations After Termination Date

Moomoo 24/7Apr 12 08:08 ET

Express News | Adaptimmune Therapeutics PLC: as a Result of Termination, Co Not Entitled to Receive Further Milestones or Other Payments Due After Termination Date

Moomoo 24/7Apr 12 08:08 ET

Express News | Adaptimmune Therapeutics PLC: Termination Will Become Effective 180 Days After Date of Receipt of Notice of Termination

Moomoo 24/7Apr 12 08:07 ET

Express News | Adaptimmune Therapeutics : on April 10, Unit of Co, Received Notice of Termination of Strategic Collaboration and License Agreement With Genentech

Moomoo 24/7Apr 12 08:07 ET